Medication info

Anosol Injection

Prescription medicationInjections
Ingredient · strength
L-Tryptophan›0.13g / 100mLL-Isoleucine›5.9g / 1000mLL-Leucine›7.7g / 1000mLL-Lysine Acetate›8.7g / 1000mLL-Methionine›4.5g / 1000mLL-Phenylalanine›4.8g / 1000mLL-Threonine›3.4g / 1000mLL-Tryptophan›1.3g / 1000mLL-Valine›5.6g / 1000mLL-Alanine›6g / 1000mLL-Arginine›8.1g / 1000mLL-Histidine›2.4g / 1000mLL-Proline›9.5g / 1000mLL-Serine›5g / 1000mLGlycine›11.9g / 1000mLL-Cysteine Hydrochloride Hydrate›0.2g / 1000mL
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
A transparent injection containing a colorless to pale yellow solution.
Packaging
100 milliliters/vial, 250 milliliters/vial
Approval status
Active

MFDS item code 199000010 · Notified 1990.04.03

Summary

Main use
Improvement of nutritional status (including hypoproteinemia and malnutrition) through amino acid supplementation
Who uses it
Adults · Children
Adult dosage
○Adults: Administer by intravenous drip, up to a maximum daily dose of 1~1. 5 g of total amino acids per kg of body weight. ○Rate of administration: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; as a general rule, administer by intravenous drip at a rate of 30~40 drops per minute. Adjust the dose and infusion rate for elderly patients and patients with burns who have high protein requirements.
Children's dosage
For children, adjust the dose and infusion rate before administration.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional status (including hypoproteinemia and malnutrition) through amino acid supplementation

  • Hypoproteinemia
  • malnutrition.
View approved original text

In cases of hypoproteinemia and malnutrition, as well as situations such as before and after surgery, amino acid supplementation is very important. This medication aids in protein synthesis in the body to enhance nutritional status and supports physical recovery needed in the treatment process. Particularly before and after surgery, it promotes tissue recovery to aid in rapid recovery. It is also used to supplement the protein deficiency in patients with hypoproteinemia to improve overall health.

Dosage and Administration

Adult dosage

○Adults: Administer by intravenous drip, up to a maximum daily dose of 1~1. 5 g of total amino acids per kg of body weight. ○Rate of administration: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; as a general rule, administer by intravenous drip at a rate of 30~40 drops per minute. Adjust the dose and infusion rate for elderly patients and patients with burns who have high protein requirements.

Children's dosage

For children, adjust the dose and infusion rate before administration.

Precautions

This medication must be used strictly under a doctor's guidance. It should not be administered to patients in hepatic coma or at risk of hepatic coma. Patients with severe renal impairment or hypernitrogenemia should also avoid this medication. It is not suitable for patients with metabolic disorders affecting nitrogen utilization. This medication should not be administered to patients with severe congestive heart failure or pulmonary edema. Patients with negligible or no urine output should not use this medication. In cases where sodium or chloride ions are included, it should not be given to patients with hypernatremia, hyperchloremia, or alkalosis. Patients with severe acidosis, congestive heart failure, edema due to sodium retention, or hyperkalemia or potassium retention should use it with caution. Patients with compromised liver or kidney function also need care. As sodium bisulfite is included, individuals allergic to sulfites or asthmatic patients may experience severe allergic reactions, so care is needed. Rarely, skin rashes and other hypersensitivity reactions may occur, and in such cases, use should be discontinued immediately. Gastrointestinal symptoms such as nausea or vomiting may occur. Cardiac symptoms like chest discomfort, palpitations, rapid pulse, and increased blood pressure may occur. Rapid administration of large amounts may lead to acidosis. Chills, fever, headache, shortness of breath, shock, bronchospasm, and urinary spasms may occur. Metabolic acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, hypoglycemia, elevated liver enzymes, vitamin deficiencies or excesses, and electrolyte imbalances may present. Patients with compromised liver or kidney function may experience increased blood urea nitrogen levels. Patients with severely impaired liver function may present with amino acid imbalance in the blood, metabolic alkalosis, and coma among other severe symptoms. In cases of large doses, attention must be paid to electrolyte balance, and it should be used with caution when used with electrolyte-containing solutions. Overdosage may lead to metabolic alkalosis, so care is necessary. Patients with kidney disease, lung disease, or severe heart disease should adjust dosage and infusion speed to prevent fluid overload. Diabetic patients should check their blood sugar levels frequently while using this medication. When used together with the specific antibiotic tetracycline, the protein-sparing effect of this medication may be reduced, so caution is advised. The safety for pregnant women has not been established, so it should only be administered when the benefits of treatment outweigh the risks. In children, the dosage and infusion speed should be adjusted, and ammonia levels in the blood checked frequently due to the risk of hyperammonemia because liver function is not fully developed. Elderly patients should have the infusion speed decreased and dosage adjusted due to declining bodily functions, and care should be taken. This medication contains electrolytes, so care must be given to electrolyte balance during high-volume administration, and the intravenous infusion speed should be slow. Rapid infusion may result in chills, vomiting, and increased amino acid loss to the kidneys. Infusion fluids should be warmed to body temperature before use, and a sterile environment should be strictly maintained during preparation and management. Before administration, check that the solution is clear and without abnormalities, and use promptly after mixing. During storage, keep sealed without opening the packaging, and do not use if the solution has changed color or leaked. Patients with a history of myocardial infarction should not use this medication.

Side effects

  • rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • shortness of breath
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • reactive hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma
  • anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture at room temperature. Avoid extremely hot or cold places and store it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

A transparent injection containing a colorless to pale yellow solution.

Package unit

100 milliliters/vial, 250 milliliters/vial

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.